IN172269B - - Google Patents

Info

Publication number
IN172269B
IN172269B IN809MA1991A IN172269B IN 172269 B IN172269 B IN 172269B IN 809MA1991 A IN809MA1991 A IN 809MA1991A IN 172269 B IN172269 B IN 172269B
Authority
IN
India
Prior art keywords
pct
date jun
sec
vesicles
pub
Prior art date
Application number
Other languages
English (en)
Inventor
Michel Schneider
Herve Tournier
Roland Hyaginthe
Christian Guillot
Bernard Lamy
Original Assignee
Sint Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sint Sa filed Critical Sint Sa
Priority to IN809MA1991 priority Critical patent/IN172269B/en
Publication of IN172269B publication Critical patent/IN172269B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN809MA1991 1990-12-11 1991-10-24 IN172269B (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN809MA1991 IN172269B (fr) 1990-12-11 1991-10-24

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90810969 1990-12-11
IN809MA1991 IN172269B (fr) 1990-12-11 1991-10-24

Publications (1)

Publication Number Publication Date
IN172269B true IN172269B (fr) 1993-05-29

Family

ID=8205973

Family Applications (1)

Application Number Title Priority Date Filing Date
IN809MA1991 IN172269B (fr) 1990-12-11 1991-10-24

Country Status (20)

Country Link
US (1) US5393530A (fr)
EP (1) EP0514523B1 (fr)
JP (1) JP3241720B2 (fr)
KR (1) KR0137783B1 (fr)
AT (1) ATE131724T1 (fr)
AU (1) AU635456B2 (fr)
CA (1) CA2072559C (fr)
DE (1) DE69115682T2 (fr)
DK (1) DK0514523T3 (fr)
ES (1) ES2081605T3 (fr)
GR (1) GR3018506T3 (fr)
HU (1) HUT62458A (fr)
IE (1) IE72163B1 (fr)
IL (1) IL99835A (fr)
IN (1) IN172269B (fr)
IS (1) IS1685B (fr)
MX (1) MX9102516A (fr)
NZ (1) NZ240817A (fr)
WO (1) WO1992010166A1 (fr)
ZA (1) ZA918489B (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US6241967B1 (en) * 1992-10-16 2001-06-05 Andreas Sachse Process and device for the production of liquid, disperse systems
US5869305A (en) * 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6217849B1 (en) 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
WO1995026205A1 (fr) * 1994-03-28 1995-10-05 Nycomed Imaging A/S Liposomes
ATE207763T1 (de) * 1995-02-24 2001-11-15 Bracco Research Sa Liposomensuspensionen als blut-pool- kontrastmittel
US5738868A (en) * 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
US6447800B2 (en) 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US20010051131A1 (en) * 1996-06-19 2001-12-13 Evan C. Unger Methods for delivering bioactive agents
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
GB9624918D0 (en) * 1996-11-29 1997-01-15 Nycomed Imaging As Particulate components
AU7104598A (en) 1997-04-09 1998-10-30 Philipp Lang New technique to monitor drug delivery noninvasively (in vivo)
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
IL135060A (en) 1997-09-18 2005-12-18 Skyepharma Inc Sustained release liposomal anesthetic compositions and methods for the preparation thereof
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19813773A1 (de) * 1998-03-27 1999-09-30 Clemens Unger Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen
US6277413B1 (en) 1998-07-17 2001-08-21 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
EP1289565B1 (fr) 2000-06-02 2015-04-22 Bracco Suisse SA Composes pour le ciblage des cellules endotheliales
DE10121903A1 (de) * 2001-04-27 2002-10-31 Nimbus Biotechnologie Gmbh System für die Membranpermeationsmessung
EP1395243A2 (fr) * 2001-05-31 2004-03-10 SkyePharma Inc. Encapsulation de nanosuspensions dans des liposomes et des microspheres
US7615233B2 (en) * 2001-07-10 2009-11-10 Canon Kabushiki Kaisha Particulate construct comprising polyhydroxyalkanoate and method for producing it
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
US20030129224A1 (en) * 2001-11-13 2003-07-10 Paul Tardi Lipid carrier compositions and methods for improved drug retention
DE60222580T2 (de) * 2001-11-13 2008-06-12 Celator Pharmaceuticals, Inc. Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
WO2003041681A2 (fr) * 2001-11-13 2003-05-22 Celator Technologies, Inc. Compositions a vecteurs lipidiques a stabilite sanguine accrue
US20050129750A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Process for producing liposome suspension and product containing liposome suspension produced thereby
EP1547580A1 (fr) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Chargement des nanoparticules colloidales avec un principe actif de camptothécine
EP1547582A1 (fr) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Méthode de préparation de la camptothécine carboxylate complexée avec des lipides
JP4773430B2 (ja) 2004-06-03 2011-09-14 ブラッコ・リサーチ・ソシエテ・アノニム 治療および／または診断用途のためのリポソーム集合体
JP2008515929A (ja) * 2004-10-08 2008-05-15 アルザ コーポレイション 脂質連結部分を予備形成した脂質集合体にマイクロ波を使用して挿入する方法
WO2006081354A2 (fr) * 2005-01-26 2006-08-03 Celator Pharmaceuticals, Inc. Compositions de porteur lipidique a degre de polydispersion reduit
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
ES2275443B1 (es) * 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
JP5080779B2 (ja) * 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
US20110059549A1 (en) * 2007-05-09 2011-03-10 Coleman Matthew A Methods and systems for producing nanolipoprotein particles
US9040079B2 (en) * 2007-11-19 2015-05-26 Biolitec Pharma Marketing Ltd Pegylated compounds for age-related macular degeneration
US9688718B2 (en) * 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
US8883729B2 (en) * 2008-05-22 2014-11-11 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
AU2009301141B2 (en) 2008-10-07 2015-08-27 Bracco Suisse S.A. Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
EP2184054A1 (fr) * 2008-11-08 2010-05-12 Lipoxen Technologies Limited Livraison ARN à faible interférence
US10151037B2 (en) 2009-01-12 2018-12-11 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide dependent target reduction, and related methods and systems
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2480208A1 (fr) 2009-09-23 2012-08-01 Indu Javeri Méthodes de préparation de liposomes
US10736844B2 (en) 2011-01-13 2020-08-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
AU2013208693B2 (en) 2012-01-12 2017-12-07 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2894467A1 (fr) * 2012-01-27 2013-08-01 Variation Biotechnologies Inc. Procedes de preparation de compositions thermostables comprenant un compose lipidique et des agents therapeutiques thermolabiles
US9801862B2 (en) 2013-11-05 2017-10-31 Gustavo A. Garcia-Sánchez Immunosuppressive treatments, formulations and methods
JP6276847B2 (ja) * 2014-04-30 2018-02-07 富士フイルム株式会社 リポソーム組成物及びその製造方法
PT3138555T (pt) 2014-04-30 2020-12-15 Fujifilm Corp Composição lipossómica e método de produção da mesma
EP4154915A1 (fr) 2014-12-31 2023-03-29 Lantheus Medical Imaging, Inc. Compositions de microsphères gazeuses enrobées de lipides et procédés connexes
MX2017014130A (es) 2015-05-04 2018-07-06 Versantis AG Metodo para preparar vesiculas con gradiente de ph de transmembrana.
US11279749B2 (en) 2015-09-11 2022-03-22 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
MA43184A (fr) * 2015-11-02 2021-04-14 Fujifilm Corp Composition liposomale et son procédé de production
MX2018013409A (es) 2016-05-04 2019-07-08 Lantheus Medical Imaging Inc Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
SG11202113005SA (en) * 2019-06-28 2021-12-30 Univ Texas Method of reconstituting liposomal annamycin
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CA1270198A (fr) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation d'agents antineoplastiques dans des liposones
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
JPS63211222A (ja) * 1987-02-27 1988-09-02 Terumo Corp リポソ−ムの製法
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
CH672733A5 (fr) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4870160A (en) * 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
IE63518B1 (en) * 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
CA1330199C (fr) * 1987-12-22 1994-06-14 Thomas D. Madden Vesiculation spontanee de liposomes multilamellaires
EP0414806B1 (fr) * 1988-05-20 1994-07-20 The Liposome Company, Inc. Complexe agent actif:lipide a rapport eleve
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release

Also Published As

Publication number Publication date
IS3773A7 (is) 1992-06-12
MX9102516A (es) 1992-06-01
KR0137783B1 (ko) 1998-05-15
JP3241720B2 (ja) 2001-12-25
CA2072559A1 (fr) 1992-06-12
IE72163B1 (en) 1997-03-26
ZA918489B (en) 1992-07-29
JPH05504150A (ja) 1993-07-01
DK0514523T3 (da) 1996-01-29
CA2072559C (fr) 1997-03-18
GR3018506T3 (en) 1996-03-31
EP0514523A1 (fr) 1992-11-25
AU635456B2 (en) 1993-03-18
WO1992010166A1 (fr) 1992-06-25
KR920703014A (ko) 1992-12-17
DE69115682D1 (de) 1996-02-01
NZ240817A (en) 1993-01-27
IE914289A1 (en) 1992-06-17
DE69115682T2 (de) 1996-05-15
HUT62458A (en) 1993-05-28
IL99835A (en) 1995-11-27
ATE131724T1 (de) 1996-01-15
IS1685B (is) 1998-02-24
IL99835A0 (en) 1992-08-18
EP0514523B1 (fr) 1995-12-20
AU9062991A (en) 1992-07-08
ES2081605T3 (es) 1996-03-16
US5393530A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
IN172269B (fr)
PL339768A1 (en) Method of encapsulating aromatic and taste giving substances by controllable delivery of water into microcapsules
EP0140085A3 (en) Drug-containing lipid vesicle preparation and method for preparing them
MY107940A (en) Microemulsified siliconnes in liquid fabric care composition containing dye.
GR3015731T3 (en) Use of interfacially-polymerized membranes in delivery devices.
NO901852L (no) Fremgangsmaate for fremstilling av liposomer.
ES2039759T3 (es) Preparados estables, dispersables en agua fria.
HK1008774A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
IL86211A (en) Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
CA2177695A1 (fr) Procede de transmission, a une cellule, d'une substance a activite biologique
EP0126580A3 (en) Vesicle formulations for the controlled release of therapeutic agents
IL104348A (en) Hair preparation containing cysteamine and permanent wave method
ATE150735T1 (de) Lagerstabil verkapseltes natriumpercarbonat und verfahren zu seiner herstellung
DE69305080D1 (de) Alginatfasern mit verzögerter wirkstofffreigabe und verfahren zu deren herstellung
TW260653B (fr)
EP0313008A3 (en) Magnetic membrane capsules and their use
HU9502855D0 (en) Method of encapsulating substances in biocapsules
Kasatkin State of Yb impurities in InP crystals.
IL88599A0 (en) Glycoprotein cell growth modulating materials,their preparation and compositions containing them
Arizmendi et al. Growth of single crystals of LiNbO sub 3
Talalaeva et al. Peculiarities of the Magnetocaloric Effect in Single Crystal Tb sub 0. 78 Gd sub 0. 22
JPS57152874A (en) Food tablet
Witt Preparation of InP by solution and melt growth techniques
Cookson et al. Convenient synthesis of allenyl sulphides; application to the synthesis of αβ-unsaturated ketones
VINSON a) Biosystematics and Genetics b) Host relations and Biology c) Physiology and behaviour d) Ecology and Population Dynamics e) Rearing (in vivo & in vitro), Production and Release